Inventiva IVA
NASDAQ IVA
$3.61 +0.06 (+1.55%)
As of: Oct 22, 2026 · 3:59 PM EDT

Inventiva (IVA) Net Equity Issued and Repurchased (2020)

Updated

Analysis

Inventiva (IVA) Net Equity Issued and Repurchased (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -9.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -346.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Inventiva 675.29 Mn -155.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 15,420.44
Mar 31, 2020 16.21 Mn
API Access

Inventiva Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IVA&period=max&api_key=YOUR_API_KEY